Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 6:26 PM View:  | Recursion Pharmaceuticals, ... (RXRX) | 15-Nov-24 | Payment of Exercise | 11,937 | $6.18 | $73,711.00 | (< 1%) 1.5M to 1.49M | |
| 14-Nov-24 7:19 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 13-Nov-24 | Option Exercise | 39,375 | $2.22 | $87,412.50 | 3% 1.48M to 1.51M | |
| 14-Nov-24 7:19 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 13-Nov-24 | Planned Option Sale | 15,000 | $7.66 | $114,876.00 | (< 1%) 1.51M to 1.5M | |
| 14-Nov-24 7:19 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 12-Nov-24 | Option Exercise | 39,375 | $2.22 | $87,412.50 | 3% 1.45M to 1.49M | |
| 14-Nov-24 7:19 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 12-Nov-24 | Planned Option Sale | 15,000 | $7.64 | $114,628.00 | (1%) 1.49M to 1.48M | |
| 10-Oct-24 6:40 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 09-Oct-24 | Option Exercise | 39,375 | $2.22 | $87,412.50 | 3% 1.43M to 1.47M | |
| 10-Oct-24 6:40 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 09-Oct-24 | Planned Option Sale | 15,000 | $6.36 | $95,374.50 | (1%) 1.47M to 1.45M | |
| 10-Oct-24 6:40 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 08-Oct-24 | Option Exercise | 39,375 | $2.22 | $87,412.50 | 3% 1.4M to 1.44M | |
| 10-Oct-24 6:40 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 08-Oct-24 | Planned Option Sale | 15,000 | $6.32 | $94,756.50 | (1%) 1.44M to 1.43M | |
| 12-Sep-24 6:28 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 11-Sep-24 | Option Exercise | 39,375 | $2.22 | $87,412.50 | 3% 1.38M to 1.42M | |
| 12-Sep-24 6:28 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 11-Sep-24 | Planned Option Sale | 15,000 | $6.32 | $94,729.50 | (1%) 1.42M to 1.4M | |
| 12-Sep-24 6:28 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 10-Sep-24 | Option Exercise | 39,375 | $2.22 | $87,412.50 | 3% 1.35M to 1.39M | |
| 12-Sep-24 6:28 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 10-Sep-24 | Planned Option Sale | 15,000 | $6.17 | $92,499.00 | (1%) 1.39M to 1.38M | |
| 15-Aug-24 5:24 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 14-Aug-24 | Option Exercise | 39,375 | $2.22 | $87,412.50 | 3% 1.34M to 1.38M | |
| 15-Aug-24 5:24 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 14-Aug-24 | Planned Option Sale | 15,000 | $6.35 | $95,251.50 | (1%) 1.38M to 1.37M | |
| 15-Aug-24 5:24 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 13-Aug-24 | Option Exercise | 39,375 | $2.22 | $87,412.50 | 3% 1.32M to 1.36M | |
| 15-Aug-24 5:24 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 13-Aug-24 | Planned Option Sale | 15,000 | $6.35 | $95,182.50 | (1%) 1.36M to 1.34M | |
| 11-Jul-24 4:51 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 10-Jul-24 | Option Exercise | 39,375 | $2.22 | $87,412.50 | 3% 1.29M to 1.33M | |
| 11-Jul-24 4:51 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 10-Jul-24 | Planned Option Sale | 15,000 | $7.24 | $108,576.00 | (1%) 1.33M to 1.32M | |
| 11-Jul-24 4:51 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 09-Jul-24 | Option Exercise | 39,375 | $2.22 | $87,412.50 | 3% 1.27M to 1.31M | |
| 11-Jul-24 4:51 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 09-Jul-24 | Planned Option Sale | 15,000 | $7.32 | $109,778.00 | (1%) 1.31M to 1.29M | |
| 17-Jun-24 5:46 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 14-Jun-24 | Option Exercise | 39,375 | $2.22 | $87,412.50 | 3% 1.24M to 1.28M | |
| 17-Jun-24 5:46 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 14-Jun-24 | Planned Option Sale | 15,000 | $9.27 | $139,082.00 | (1%) 1.28M to 1.27M | |
| 17-Jun-24 5:46 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 13-Jun-24 | Option Exercise | 39,375 | $2.22 | $87,412.50 | 3% 1.22M to 1.26M | |
| 17-Jun-24 5:46 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 13-Jun-24 | Planned Option Sale | 15,000 | $9.32 | $139,798.00 | (1%) 1.26M to 1.24M | |
| 17-May-24 7:11 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-May-24 | Payment of Exercise | 11,962 | $10.01 | $119,740.00 | (< 1%) 1.23M to 1.22M | |
| 18-Apr-24 5:12 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 17-Apr-24 | Option Exercise | 37,500 | $2.22 | $83,250.00 | 3% 1.22M to 1.25M | |
| 18-Apr-24 5:12 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 17-Apr-24 | Planned Option Sale | 23,124 | $7.58 | $175,349.00 | (2%) 1.25M to 1.23M | |
| 18-Apr-24 5:12 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Apr-24 | Option Exercise | 37,500 | $2.22 | $83,250.00 | 3% 1.2M to 1.24M | |
| 18-Apr-24 5:12 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Apr-24 | Planned Option Sale | 25,000 | $7.67 | $191,658.00 | (2%) 1.24M to 1.22M | |
| 14-Mar-24 7:28 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 13-Mar-24 | Option Exercise | 37,500 | $2.22 | $83,250.00 | 3% 1.19M to 1.23M | |
| 14-Mar-24 7:28 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 13-Mar-24 | Planned Option Sale | 25,000 | $11.03 | $275,815.00 | (2%) 1.23M to 1.2M | |
| 14-Mar-24 7:28 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 12-Mar-24 | Option Exercise | 37,500 | $2.22 | $83,250.00 | 3% 1.18M to 1.22M | |
| 14-Mar-24 7:28 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 12-Mar-24 | Planned Option Sale | 25,000 | $10.45 | $261,375.00 | (2%) 1.22M to 1.19M | |
| 16-Feb-24 7:59 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Feb-24 | Payment of Exercise | 7,172 | $12.43 | $89,148.00 | (< 1%) 1.19M to 1.18M | |
| 15-Feb-24 6:00 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 14-Feb-24 | Option Exercise | 37,500 | $2.22 | $83,250.00 | 3% 1.17M to 1.21M | |
| 15-Feb-24 6:00 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 14-Feb-24 | Planned Option Sale | 25,000 | $10.46 | $261,425.00 | (2%) 1.21M to 1.19M | |
| 15-Feb-24 6:00 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 13-Feb-24 | Option Exercise | 37,500 | $2.22 | $83,250.00 | 3% 1.16M to 1.2M | |
| 15-Feb-24 6:00 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 13-Feb-24 | Planned Option Sale | 25,000 | $9.86 | $246,560.00 | (2%) 1.2M to 1.17M | |
| 13-Feb-24 7:01 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 09-Feb-24 | Grant | 182,849 | -- | -- | 19% 981.01K to 1.16M | |
| 13-Feb-24 7:01 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 09-Feb-24 | Payment of Exercise | 2,512 | $10.09 | $25,346.10 | (< 1%) 1.16M to 1.16M | |
| 18-Jan-24 6:37 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 17-Jan-24 | Option Exercise | 37,500 | $2.22 | $83,250.00 | 4% 968.51K to 1.01M | |
| 18-Jan-24 6:37 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 17-Jan-24 | Planned Option Sale | 25,000 | $10.25 | $256,347.00 | (2%) 1.01M to 981.01K | |
| 18-Jan-24 6:37 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Jan-24 | Option Exercise | 37,500 | $2.22 | $83,250.00 | 4% 956.01K to 993.51K | |
| 18-Jan-24 6:37 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Jan-24 | Planned Option Sale | 25,000 | $10.45 | $261,160.00 | (3%) 993.51K to 968.51K | |
| 14-Dec-23 6:53 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 13-Dec-23 | Option Exercise | 37,500 | $2.22 | $83,250.00 | 4% 943.51K to 981.01K | |
| 14-Dec-23 6:53 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 13-Dec-23 | Planned Option Sale | 25,000 | $7.59 | $189,770.00 | (3%) 981.01K to 956.01K | |
| 14-Dec-23 6:53 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 12-Dec-23 | Option Exercise | 37,500 | $2.22 | $83,250.00 | 4% 931.01K to 968.51K | |
| 14-Dec-23 6:53 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 12-Dec-23 | Planned Option Sale | 25,000 | $7.39 | $184,868.00 | (3%) 968.51K to 943.51K | |
| 16-Nov-23 6:54 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Nov-23 | Payment of Exercise | 7,172 | $7.18 | $51,495.00 | (< 1%) 963.19K to 956.01K |